Bengaluru-based digital healthcare platform MediBuddy has posted a strong financial performance for the financial year ended March 2025 (FY25), reflecting steady revenue growth and a sharp reduction in losses. The company reported an operating revenue of ₹724.6 crore in FY25, marking a 12.3% year-on-year increase from ₹645.4 crore recorded in FY24. The improved numbers indicate better scale, tighter cost controls, and rising demand for digital healthcare services across India.
Core Healthcare Services Power Revenue Growth
The revenue growth in FY25 was largely driven by MediBuddy’s core healthcare offerings. These include online and offline doctor consultations, medicine delivery, diagnostic testing, elective and non-elective surgeries, and health insurance-related services. Collectively, these segments contributed around ₹722 crore to the company’s operating income. Additional operating income of about ₹2.5 crore came from other sources within the business.
Alongside operating revenue, MediBuddy also generated ₹18.4 crore in non-operating income, which primarily included interest from fixed deposits, investment income, and other miscellaneous sources. This pushed the company’s total income for FY25 to nearly ₹743 crore, highlighting diversified income streams beyond its core platform services.
Costs Stay Flat, Helping Narrow Losses
Despite growing operations, MediBuddy managed to keep its overall expenses largely under control. Total expenditure for FY25 stood at approximately ₹879 crore, nearly unchanged from the previous year. The biggest cost component continued to be material and service procurement, which accounted for about ₹333 crore, or nearly 38% of total expenses.
Employee benefit expenses rose modestly to ₹176.8 crore, an increase of around 8% year-on-year, including ₹6 crore in ESOP-related costs. Other notable expenses included safety and security costs of ₹42.5 crore, technology and IT infrastructure spend of ₹32.5 crore, and a combined ₹138.7 crore towards advertising, legal and professional fees, depreciation, and finance-related expenses.
Losses Shrink by 37% in FY25
Improved revenue visibility and disciplined spending helped MediBuddy significantly reduce its losses in FY25. The company reported a net loss of around ₹137 crore, down from ₹215.7 crore in FY24, translating into a 37% reduction in losses. For every rupee earned, MediBuddy spent about ₹1.21, reflecting ongoing efficiency gains even as it continues to invest in growth.
The company’s EBITDA margin improved sharply to -14.19% in FY25, compared to -25.67% in the previous year. Although the EBITDA remained negative at around ₹103 crore, the improvement signals progress toward long-term profitability.
Strong Balance Sheet and Funding Support
As of March 2025, MediBuddy reported current assets worth ₹395.2 crore, including nearly ₹80 crore in cash and bank balances. This financial cushion provides the company with flexibility to continue investing in technology, expanding service offerings, and strengthening partnerships across India’s healthcare ecosystem.
To date, MediBuddy has raised over $190 million in funding from a mix of global and domestic investors, helping it scale its platform, expand into new service categories, and build a pan-India presence.
Positioned for the Next Phase of Growth
Founded in 2013, MediBuddy has emerged as a key player in India’s fast-growing healthtech space. With rising digital adoption, increasing healthcare awareness, and demand for convenient medical access, the company is well-positioned to benefit from long-term structural trends in the Indian healthcare market.
The strong FY25 performance underscores MediBuddy’s focus on sustainable growth, operational discipline, and gradual movement towards profitability, making it a closely watched name in India’s digital healthcare landscape.